Article Details

FDA Grants Breakthrough Device Designation to Tempus' Atrial Fibrillation ECG Analysis Platform ...

Retrieved on: 2021-03-24 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

FDA Grants Breakthrough Device Designation to Tempus' Atrial Fibrillation ECG Analysis Platform .... View article details on hiswai:

Excerpt

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the ...

Article found on: www.oaoa.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up
Book a Demo